The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Cherviakov Iu.V.

Kafedra khirurgii instituta poslediplomnogo obrazovaniia GOU VPO Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii Minzdrava Rossii;
GBUZ IaO "Oblastnaia klinicheskaia bol'nitsa", Iaroslavl'

Staroverov I.N.

Kafedra khirurgii instituta poslediplomnogo obrazovaniia GOU VPO Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii Minzdrava Rossii;
GBUZ IaO "Oblastnaia klinicheskaia bol'nitsa", Iaroslavl'

Nersesian E.G.

Gorodskaia bol'nitsa skoroĭ meditsinskoĭ pomoshchi, Vorkuta

Vlasenko O.N.

Kafedra khirurgii instituta poslediplomnogo obrazovaniia Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii Minzdrava RF

Isaev A.A.

Kafedra detskoĭ khirurgii MGMSU, Moskva

The opportunities for genic therapy of chronic obliterating diseases of lower limbs arteries

Authors:

Cherviakov Iu.V., Staroverov I.N., Nersesian E.G., Vlasenko O.N., Isaev A.A.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2014;(4): 40‑45

Read: 2092 times


To cite this article:

Cherviakov IuV, Staroverov IN, Nersesian EG, Vlasenko ON, Isaev AA. The opportunities for genic therapy of chronic obliterating diseases of lower limbs arteries. Pirogov Russian Journal of Surgery. 2014;(4):40‑45. (In Russ.)

Recommended articles:
Vita­min D role in oral cavity diseases. Stomatology. 2025;(1):81-86

References:

  1. Bokerija L.A. Vozmozhnosti ispol'zovanija gennyh i kletochnyh tehnologij dlja lechenija serdechno-sosudistyh zabolevanij. Bjulleten' NC SSH im. A.N. Bakuleva RAMN 2004; 3: 19-38.
  2. Bokerija L.A., Alekjan B.G. Otchet o sostojanii serdechno-sosudistoj hirurgii v RF za 2012 g. M 2013; 73.
  3. Gavrilenko A.V., Skrylev S.I., Kuzubova E.A. Sovremennye vozmozhnosti i perspektivy hirurgicheskogo lechenija bol'nyh s kriticheskoj ishemiej nizhnih konechnostej. Angiol i sosud hir 2002; 8: 4: 80-86.
  4. Gavrilenko A.V., Voronov D.A., Bochkov N.P. Kompleksnoe lechenie pacientov s hronicheskoj ishemiej nizhnih konechnostej s ispol'zovaniem gennyh induktorov angiogeneza: blizhajshie i otdalennye rezul'taty. Kletochnaja transplantologija i tkanevaja inzhenerija 2011; 6: 3: 84-85.
  5. Grirorjan A.S., Shevchenko K.G. Vozmozhnye molekuljarnye mehanizmy funkcionirovanija plazmidnyh konstrukcij soderzhashhih gen VEGF. Kletochnaja transplantologija i tkanevaja inzhenerija 2011; 6: 3: 24-28.
  6. Deev R.V., Kalinin R.V., Chervjakov Ju.V. i dr. Rezul'taty primenenija genterapevticheskogo preparata "Neovaskulgen" u pacientov s hronicheskoj ishemiej nizhnih konechnostej; 1 god nabljudenij. Vestnik Nacional'nogo mediko-hirurgicheskogo centra im. N.I. Pirogova 2011; 6: 4: 20-26.
  7. Deev R.V., Chervjakov Ju.V., Kalinin R.E. i dr. Teoreticheskie i prakticheskie aspekty primenenija preparata na osnove nukleinovoj kisloty, kodirujushhej jendotelial'nyj sosudistyj faktor rosta ("Neovaskulgen"). Jelektronnyj zhurnal ANGIOLOGIA.ru, 2011. - rezhim dostupa k zhurn.: http://www.angiologia.ru/journal_angiologia/001_2011/
  8. Deev R.V., Grigorjan A.S., Potapov I.V. i dr. Mirovoj opyt i tendencii gennoj terapii ishemicheskih zabolevanij. Angiol i sosud hir 2011; 17: 2: 145-154.
  9. Nacional'nye rekomendacii po vedeniju pacientov s patologiej arterij nizhnih konechnostej. Angiol i sosud hir (Prilozhenie) 2013; 19: 2: 1-67.
  10. Pokrovskij A.V., Gontarenko V.N. Sostojanie sosudistoj hirurgii v Rossii v 2012 g. M 2013; 53.
  11. Talickij K.A., Bulkina O.S., Aref'eva T.I., Vorob'eva O.N. i dr. Jeffektivnost' terapevticheskogo angiogeneza u bol'nyh s hronicheskoj ishemiej nizhnih konechnostej. Kletochnaja transplantologija i tkanevaja inzhenerija 2011; 6: 3: 89-98.
  12. Shval'b P.G., Gavrilenko A.V., Kalinin R.E. dr. Jeffektivnost' i bezopasnost' primenenija preparata "Neovaskulgen" v kompleksnoj terapii pacientov s hronicheskoj ishemiej nizhnih konechnostej (II B - III faza klinicheskih ispytanij). Kletochnaja transplantologija i tkanevaja inzhenerija 2011; 6: 3: 76-83.
  13. Shojhet Ja.N., Horev N.G. Kletochnye tehnologii v lechenii zabolevanij perifericheskih arterij. Kletochnaja transplantologija i tkanevaja inzhenerija 2011; 6: 3: 15-23.
  14. Chervjakov Ju.V., Staroverov I.N., Nersesjan E.G. i dr. Terapevticheskij angiogenez v lechenii bol'nyh s hronicheskimi obliterirujushhimi zabolevanijami arterij nizhnih konechnostej. Blizhajshie i otdalennye rezul'taty. Angiol i sosud hir 2012; 3: 19-27.
  15. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nature Medicine 2003; 9: 669-676.
  16. Ferraro B., Cruz Y.L., Baldwin M. et al. Increased perfusion and angiogenesis in a hind limb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation. Gene Therapy 2010; 17: 763-769.
  17. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 21: 1182-1186.
  18. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease. J Am Coll Cardiol 2006; 47: 6: 1239-1312.
  19. Nicol S. Viral or non-viral angiogenesis gene transfer - New answers to old questions. Cardiovasc Res 2007; 73: 443-445.
  20. Norgren L., Hiatt W.R., Dormandy J.A. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33: 1-70.
  21. Sylven C. Angiogenic gene therapy. Drugs of today 2002; 38: 819-827.
  22. Tongers J., Roncalli J.G., Losordo D.W. Therapeutic Angiogenesis for Critical Limb Ischemia. Microvascular Therapies Coming of Age 2008; 118: 9-16.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.